Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.

Cowey CL, Amin C, Pruthi RS, Wallen EM, Nielsen ME, Grigson G, Watkins C, Nance KV, Crane J, Jalkut M, Moore DT, Kim WY, Godley PA, Whang YE, Fielding JR, Rathmell WK
J Clin Oncol. 2010 28 (9): 1502-7

PMID: 20159822 · PMCID: PMC4525128 · DOI:10.1200/JCO.2009.24.7759

MeSH Terms (22)

Adult Aged Aged, 80 and over Antineoplastic Agents Benzenesulfonates Carcinoma, Renal Cell Feasibility Studies Female Humans Kidney Neoplasms Male Middle Aged Neoadjuvant Therapy Neoplasm Staging Niacinamide Phenylurea Compounds Pilot Projects Prospective Studies Pyridines Sorafenib Treatment Outcome Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: